EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOMYG00000034046
Gene Symbol: DHCR24
1 Cross references
202 Possible Orthologues:

24-Dehydrocholesterol Reductase

Ensembl ID : ENSOMYG00000000432
Gene Symbol: DHCR24
2 Cross references
202 Possible Orthologues:

26 Proteasome Complex Subunit Dss1

Ensembl ID : ENSOMYG00000012077
Gene Symbol: DSS1
3 Cross references
149 Possible Orthologues:

26s Proteasome Non-Atpase Regulatory Subunit 6

Ensembl ID : ENSOMYG00000006222
Gene Symbol: PSD6
2 Cross references
206 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSOMYG00000013864
Gene Symbol: HMGCR
2 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSOMYG00000006390
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSOMYG00000031301
Gene Symbol: PDPK1A
1 Cross references
165 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1b

Ensembl ID : ENSOMYG00000021496
Gene Symbol: PDPK1B
1 Cross references
214 Possible Orthologues:

40s Ribosomal Protein S13

Ensembl ID : ENSOMYG00000033854
Gene Symbol: RS13
2 Cross references
22 Possible Orthologues:

40s Ribosomal Protein S14

Ensembl ID : ENSOMYG00000042616
Gene Symbol: RS14
3 Cross references
163 Possible Orthologues:

40s Ribosomal Protein S15

Ensembl ID : ENSOMYG00000037667
Gene Symbol: RS15
3 Cross references
329 Possible Orthologues:

40s Ribosomal Protein S25

Ensembl ID : ENSOMYG00000047081
Gene Symbol: RS25
3 Cross references
444 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).